Barclays »

Amphastar Pharmaceuticals In shares owned by Barclays

Quarter-by-quarter ownership of Amphastar Pharmaceuticals In shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Amphastar Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals In held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals In by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $298k 328k 0.91
2025-06-30 $319k 369k 0.86
2025-03-31 $318k 358k 0.89

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Amphastar Pharmaceuticals In

Linden Advisors
Camden Asset Management
Wellesley Investment Advisors
Oaktree Capital Management
Empyrean Capital Partners
Tenor Capital Management
Silverback Asset Management
Calamos Advisors
MacKay Shields
Leucadia National Corporation
Russell Investments
FMR
BlackRock
Advent Capital Management
CSS

View all funds holding Amphastar Pharmaceuticals In